EMD-72737

Single-particle
30.0 Å
EMD-72737
3D View Gallery
Deposition: 16/09/2025
Map released: 22/10/2025
Last modified: 17/06/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-72737
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
EMICSS annotations (xml)

HIV-1 Env Q23 NFL TD CC3+ in complex with NHP Q12 V2-apex polyclonal antibody Fabs isolated post-2 immunizations

EMD-72737

Single-particle
30.0 Å
EMD-72737
3D View Gallery
Deposition: 16/09/2025
Map released: 22/10/2025
Last modified: 17/06/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Macaca mulatta, Human immunodeficiency virus 1
Sample: HIV-1 Env Q23 NFL TD CC3+ in complex with NHP Q12 V2-apex polyclonal antibody Fabs isolated post-2 immunizations

Deposition Authors: Lee W-H , Ozorowski G , Ward AB
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.
Guenaga J, Adori M, Bale S, Phulera S, Zygouras I, Schleich FA, Castro Dopico X , Agrawal S, Ota M, Wilson R, Cluff J, Dzvelaia T, Mandolesi M, Lee WH, Walsh AA, Melo MB, Verkoczy L, Irvine DJ, Corcoran M, Wilson IA, Carnathan D, Silvestri G, Ward AB , Ozorowski G , Karlsson Hedestam GB, Wyatt RT
(2026) Nature
PUBMED: 42056526
DOI: doi:10.1038/s41586-026-10429-3
ISSN: 1476-4687
ASTM: NATUAS